| GEMP Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||
Below is a table of the GEMP shares outstanding history going back to 8/5/2016:
Also see: GEMP Market Cap History GEMP YTD Return |
GEMP Shares Outstanding History — Gemphire Therapeutics Share Count Over Time
As of 11/6/2019 Gemphire Therapeutics has 14.87 million GEMP shares outstanding. Investors often track the GEMP shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows GEMP share count trends over time, with 16 historical shares outstanding datapoints presented, dating back to 8/5/2016.
| GEMP Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||
GEMP Historical Shares Outstanding: +15.97% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||
| GEMP Stock Price Chart |
| About NeuroBo Pharmaceuticals Inc |
| Gemphire Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of dyslipidemia, a medical condition that increases the risk of life-threatening cardiovascular disease, focused on orphan indications, as well as nonalcoholic fatty liver disease. Co.'s product candidate, gemcabene, has been tested as monotherapy and in combination with statins and other drugs. Within dyslipidemia, indications include Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, Severe Hypertriglyceridemia and Nonalcoholic Steatohepatitis. We show 16 historical shares outstanding datapoints in our coverage of GEMP's shares outstanding history. Understanding the changing numbers of GEMP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GEMP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GEMP by allowing them to research GEMP shares outstanding history as well as any other stock in our coverage universe. |
| GEMP Current Stock Quote |
Quotes delayed 20 minutes  Free GEMP Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| GEMP Share Performance |
| Shares Outstanding Peers |
| Gemphire Therapeutics (GEMP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
GENE Shares Outstanding History GERN Shares Outstanding History GFOR Shares Outstanding History GH Shares Outstanding History GHDX Shares Outstanding History GILD Shares Outstanding History GKOS Shares Outstanding History GLSI Shares Outstanding History GLTO Shares Outstanding History GLUE Shares Outstanding History More Healthcare companies » |
GEMP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
